Location History:
- Cardiff, CA (US) (1990 - 2017)
- Cardiff-By-The-Sea, CA (US) (1993 - 2019)
Company Filing History:
16 out of 1,187 
2 out of 122 
2 out of 2 Years Active: 1990-2019
Title: Innovations by J Gregor Sutcliffe: A Pioneer in Alzheimer’s Research
Introduction
J Gregor Sutcliffe, based in Cardiff, CA, is a distinguished inventor known for his significant contributions to the field of medical research, particularly in Alzheimer's disease. Holding 20 patents, Sutcliffe has dedicated his career to developing innovative solutions to reduce amyloid-beta load, which is crucial for understanding and treating neurodegenerative disorders.
Latest Patents
Among the latest patents attributed to J Gregor Sutcliffe are groundbreaking compositions and methods aimed at reducing amyloid-beta peptide (Aβ) levels in non-neuronal cells, fluids, and tissues. His inventions focus on the selective modulation of γ-secretase activity, which has implications for preventing and treating Aβ-related disorders. This includes methods to improve symptoms associated with brain Aβ disorders, such as Alzheimer's disease. Sutcliffe's work not only highlights the importance of amyloid-beta modulation but also presents new approaches to combat this critical public health issue.
Career Highlights
Throughout his career, J Gregor Sutcliffe has been associated with esteemed institutions such as The Scripps Research Institute and the Scripps Clinic and Research Foundation. His work at these research institutions has placed him at the forefront of scientific innovation, allowing for substantial advancements in the understanding of Alzheimer's and other related diseases.
Collaborations
In his professional journey, Sutcliffe has collaborated with notable peers, including Mark G Erlander and Karl W Hasel. These collaborations have facilitated an exchange of ideas and expertise, contributing significantly to the progress of research in modulating amyloid-beta levels and furthering the fight against neurodegenerative disorders.
Conclusion
J Gregor Sutcliffe's dedication to innovation in the medical realm, particularly through his patented work on amyloid-beta reduction, marks him as a critical figure in the scientific community. His efforts not only advance research but also aim to provide solutions that can transform the lives of those impacted by Alzheimer's disease and similar disorders. With ongoing efforts and innovative ideas, Sutcliffe continues to pave the way for future discoveries in medical science.